As the world makes great strides in the development of artificial intelligence, some companies believe AI may hold the key to accelerating the cure for some of the world’s most insidious diseases
BARNARD, VT / ACCESSWIRE / March 24, 2023 / America is in the midst of a public health crisis. According to the CDC, six in 10 adults struggle with one chronic illness, while four in 10 adults struggle with two or more chronic illnesses. Every year in the United States, we spend $4.1 trillion in healthcare costs.
And the statistics get even grimmer when you look at the global health crisis. In 2019, 87.8% of deaths in high-income countries were due to noncommunicable diseases, with dementia, heart disease and stroke being the driving force. Meanwhile, cancer continues to wreak havoc worldwide, with 18.1 million cases in 2020.
At the beginning of the 21st century, people made incredible strides in scientific advances. Jonas Salk developed the polio vaccine, Alexander Fleming discovered antibiotics and humanity experienced a medical boom. Fast forward to today, where unfortunately major medical advances have stalled.
Some experts suggest part of the problem is that many of the world’s top thinkers are excluded from the discussion. The pool of scientists with the resources to produce effective research is small and exclusive, while political and legal hurdles hamper the cross-border exchange of information with other scientists. In addition, human error makes research prone to error, and economic incentives impede growth rather than encourage it.
But that could change thanks to the rise of artificial intelligence. As AI advances, many of these programs are as smart as doctors. The impact is profound as the AI now grants regular citizen scientists direct access to medical education.
“Individuals are passionate about solving their diseases,” says Doctor Justin Lancaster of kwiKBio Inc. “Artificial intelligence gives people an outlet and the tools to fight these diseases head-on.”
KwiKBio Inc and other AI programs use advanced research methods to accelerate research and connect over 50 million citizens so our world can solve diseases sooner. Rather than keeping most of the world’s minds out of the race to cure disease, AI allows everyone to work together to accelerate cures.
“We believe that governments, universities and biomedical companies have the wrong incentives to achieve the desired outcome, which is to solve diseases quickly,” continues Dr. Lancaster away. “Instead, these institutions often want to grow and control resources. To accelerate science, we must put it in the hands of passionate citizens.”
dr Lancaster’s hope is that this collaborative atmosphere will bring humanity closer to finding tomorrow’s cures, rather than waiting for the next hundred years. This could be possible with artificial intelligence.
AROUND
KwiKBio is a medical research company that harnesses the power of AI to enable citizen scientists to find cures for diseases. While traditional science is slow and for-profit, kwiKBio uses a crowdsourcing model, AI and computing technology to discover cures at an accelerated pace. KwiKBio’s four US patents combine a research system and electronic marketplace for medical and biomedical research services. Visit the kwiKBio website for more information. For more information, visit kwiKBio on Facebook, Twitter or YouTube.
CONTACT
dr Justin Lancaster
[email protected]
617-688-2785
SOURCE: kwiKBio
